Genetic variants of α1-antitrypsin

Current Protein and Peptide Science

Volumn 11, Issue 2, 2010, Pages 107-117

  Salahuddint, Parveen ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

1 antitrypsin; Aggregation; Emphysema; Genetic variants of 1 antitrypsin; Intracellular proteolysis; Liver diseases; Serpins superfamily

Indexed keywords

ALPHA 1 ANTITRYPSIN;

AMINO ACID SUBSTITUTION; BETA SHEET; EMPHYSEMA; GENE THERAPY; GENETIC VARIABILITY; HUMAN; ISOELECTRIC FOCUSING; LIVER CELL; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MUTATIONAL ANALYSIS; NONHUMAN; POLYMERIZATION; PROTEIN CONFORMATION; PROTEIN DEFICIENCY; PROTEIN FUNCTION; REVIEW; STRUCTURE ANALYSIS; ALPHA 1 ANTITRYPSIN DEFICIENCY; CHEMICAL STRUCTURE; GENETICS; METABOLISM; PHYLOGENY;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; GENETIC VARIATION; HUMANS; MODELS, MOLECULAR; PHYLOGENY;

EID: 77950179576     PISSN: 13892037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (176)

1. 1- antitrypsin. Nature, 1982, 298, 329-334.
2. 1-antitrypsin deficiency. Am. J. Med., 1988, 84, 13-31.
3. 1-antitrypsin deficiency: a previously unrecognized inherited disorder. J. Lab. Clin. Med., 1969, 73, 934-939.
4. Sveger, T. Liver disease in alpha 1-antitrypsin deficiency detected by screening of 200 000 infants. N. Engl. J. Med., 1976, 294, 1316-1321.
5. Eriksson, S.; Carlson, J.; Velez, R. Risk of cirrhosis and primary liver cancer in α1-antitrypsin deficiency. N. Engl. J. Med., 1986, 314, 736-739.
6. 1-antitrypsin by the perfused rat liver. Biochim. Biophys. Acta., 1978, 539, 496-504.
7. 1- antitrypsin. Biochim. Biophys. Acta, 1978, 542, 496-505.
8. 1-proteinase inhibitor in the human cornea by growth factors and cytokines. Biochim. Biophys. Acta., 1998, 1403, 37- 46.
9. 1-antitrypsin in the human small intestine. Histopathology., 1982, 6, 55-60.
10. 1-proteinase inhibitor gene in human monocytes and macrophages. Proc. Natl. Acad. Sci. USA., 1985, 82, 795-799.
11. Ray, M. B.; Geboes, K.; Callea, F.; Desmer, V. J. Alpha-1-antitrypsin immunoreactivity in islet cells of adult human pancreas. Cell. Tissues. Res., 1977, 185, 63-68.
12. Dabbagh, K.; Laurent, G. J.; Shock, A.; Leoni, P.; Papakrivopoulou, J.; Chambers, R.C. Alpha-1-antitrypsin stimulates fibroblast proliferation and procollagen production and activates classical MAP kinase signalling pathways. J. Cell. Physiol., 2001, 186, 73-81.
13. Jeannin, P.; Lecoanet-Henchoz, S.; Delneste, Y.; Gauchat, J. F.; Bonnefoy, J. Y. Alpha-1 antitrypsin up-regulates human B cell differentiation selectively into IgE- and IgG4-secreting cells. Eur. J. Immunol., 1998, 28, 1815-1822.
14. 1- proteinase inhibitor, α 1antichymotrypsin, and α2-macroglobulin are the antiapoptotic factors of vascular smooth muscle cells. J. Biol. Chem., 2001, 276, 11798-11803.
15. Weiss, G.; Goossenn, B.; Doppler, W.; Fuchs, D.; Pantopoulos, K.; Werner-Felmayer, G.; Wachter, H.; Hentze, M. W. Translational regulation via iron-responsive elements by the nitric oxide/NO-synthase pathway. EMBO J., 1993, 12, 3651-3657.
16. 1-antitrypsin. FEBS. Lett., 1992, 300, 21-24.
17. 1-antitrypsin inhibits growth and proliferation of human early erythroid progenitor cells (burst-forming units-erythroid) and of human erythroleukemic cells (K562) in vitro by interfering with transferrin iron uptake. Blood, 1994, 83, 260-268.
18. Churg, A.; Dai, J.; Zay, K.; Karsan, A.; Hendricks, R.; Yee, C.; Martin, R.; Mac-Kenzie, R.; Xie, C.; Zhang, L.; Shapiro, S.; Wright, J. L. Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects. Lab. Invest., 2001, 81, 1119-1131.
19. Jie, Z.; Cai, Y.; Yang, W.; Jin, M.; Zhu, W.; Zhu, C. Protective effects of alpha (1)-antitrypsin on acute lung injury in rabbits induced by endotoxin. Chin. Med. J., 2003, 116, 1678-1682.
20. Libert, C.; Van Molle, W.; Brouckaert, P.; Fiers, W. Alpha1-antitrypsin inhibits the lethal response to TNF in mice. J. Immuol., 1996, 157, 5126-5129.
21. 1-antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP. J. Biol. Chem., 2007, 282, 8573-8582.
22. 1-antitrypsin protects β-cells from apoptosis. Diabetes, 2007, 56, 1316-1323.
23. 1-antitrypsin. Biochem. Biophys. Res. Commun., 2004, 321, 592-600.
24. 1-antitrypsin. Nat. Struct. Biol., 1996, 3, 676-681.
25. 1-antitrypsin at 2.7 A°. Structure, 1996, 4, 1181-1192.
26. 1-antitrypsin is in the canonical inhibitory conformation. J. Mol. Biol., 1998, 275, 419-425.
27. 1-antitrypsin reveals targets for rational drug design to prevent conformational disease. Protein Sci., 2000, 9, 1274-1281.
28. 1-antitrypsin shows variability of the reactive center and other loops. J. Mol. Biol., 2001,306, 109-119.
29. 1-proteinase inhibitor. J. Biol. Chem., 1978, 253, 7142-7144.
30. Wilczynska, M.; Fa, M.; Ohlsson, P. I.; Ny, T. The inhibition mechanism of serpins: evidence that the mobile reactive center loop is cleaved in the native protease-inhibitor complex. J. Biol. Chem., 1995, 270, 29652-29655.
31. Wilczynska, M.; Fa, M.; Karolin, J.; Ohlsson, P. I.; Johansson, L. B. A.; Ny, T. Structural insights into serpin-protease complexes reveal the inhibitory mechanism of serpins. Nat. Struct. Biol., 1997, 4, 354-357.
32. Stratikos, E.; Gettins, P. G. W. Major proteinase movement upon stable serpin-proteinase complex formation. Proc. Natl. Acad. Sci.USA., 1997, 94, 453-458.
33. 1-proteinase inhibitor Pittsburgh. J. Biol. Chem., 1998, 273, 15582-15589.
34. Stratikos, E.; Gettins, P. G. W. Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70 A° and full insertion of the reactive center loop into beta-sheet A. Proc. Natl. Acad. Sci. USA, 1999, 96, 4808-4813.
35. Huntington, J. A.; Read, R. J.; Carrell, R. W. Structure of a serpin-protease complex shows inhibition by deformation. Nature, 2000, 407, 923-926.
36. Plotnick, M. I.; Samakur, M.; Wang, Z. M.; Liu, X.; Rubin, H.; Schechter, N. M.; Selwood, T. Heterogeneity in serpin protease complexes as demonstrated by differences in the mechanism of complex breakdown. Biochemistry, 2002, 41, 334-342.
37. Brantly, M. Diagnosis and treatment of α1-antitrypsin. The Endocrinologist., 1992, 2, 33-39.
38. Cox, D. W. In The Metabolic Basis of Inherited Disease ; Scriver, C.; Beaudet, A.; Sly, W.; Valle, D.; Eds.; McGraw-Hill Inc: New York, 2001; pp. 5559-5586.
39. Kueppers, F.; Christopherson, M. J. Alpha-1-antitrypsin: further genetic heterogeneity revealed by isoelectric focusing. Am. J. Hum. Genet., 1992, 30, 359-365.
40. 1-antitrypsin variants in a US white population. Hum. Hered., 1984, 34, 308-310.
41. 1-antitrypsin haplotype. Biochemistry, 1987, 26, 5259-5267.
42. 1-antitrypsin M3 gene, a normal variant. Hum. Genet., 1990, 85, 381-382.
43. Stoller, J. K.; Snider, G. L.; Brantly, M. American Thoracic Society/ European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am. J. Respir. Crit. Care. Med., 2003, 168, 818-900.
44. Blanco, A. D.; Al, K. D.; de Serres, F.; Fernández-Bustillo, E.; Rodríguez, M. C. Alpha1-antitrypsin polymorphism in fibromyalgia syndrome patients from the Asturias province in Northern Spain : a significantly higher prevalence of the PI*Z deficiency allele in patients than in the general population. J. Musculoskelet. Pain., 2006, 14, 5-12.
45. 1-antitrypsin. Hum. Genet., 1980, 53, 429-433.
46. 39→Cys). Hum. Genet., 1989, 84, 55-58.
47. 1- antitrypsin that is retained within the rough endoplasmic reticulum. J. Biol. Chem., 1988, 263, 7330-7335.
48. 1- antitrypsin gene associated with a frameshift to stop mutation in a coding exon. J. Biol. Chem., 1987, 262, 11999-12004.
49. 1-antitrypsin-coding exon. Am. J. Hum. Genet., 1988, 42, 77-83.
50. 1- antitrypsin. J. Clin. Invest., 1989, 83, 1144-1152.
51. 1 null allele, PI*QObolton. Hum. Genet., 1989, 83, 377-382.
52. 1-antitrypsin, QOludwigshafen, with altered tertiary structure. J. Clin. Invest., 1990, 86, 1878-1884.
53. 1-antitrypsin deficiency and the serpinopathies. Clin. Med., 2007, 7, 446-447.
54. Teramoto, S. 1. COPD pathogenesis from the viewpoint of risk factors. Intern. Med., 2007, 46, 77-79.
55. Hericks, A. J.; Bhat, A. An overview of alpha-1 antitrypsin deficiency. Mol. Med., 2007, 104, 255-259.
56. Mulgrew, A. T.; Taggart, C. C.; McElvaney, N. G. alpha-1-antitrypsin deficiency : current concepts. Lung, 2007, 185, 191-201.
57. 1-antitrypsin deficiency-associated liver disease: a meeting review. Hepatology, 2007, 45, 1313-1323.
58. Kaiserman, D.; Whisstock, J. C.; Bird, P. I. Mechanisms of serpin dysfunction in disease. Expert. Rev. Mol. Med., 2006, 8, 1-19.
59. 1-antitrypsin deficiency. Am. J. Respir. Crit. Care. Med., 2006, 173, 1072-1077.
60. Ioachimescu, O.C.; Stoller, J. K. A review of alpha-1 antitrypsin deficiency. COPD, 2005, 2, 263-275.
61. Ranes, J.; Stoller, J. K. A review of alpha-1 antitrypsin deficiency. Semin. Respir. Crit. Care. Med., 2005, 26, 154-166.
62. 1-antitrypsin deficiency and the serpinopathies. Clin. Med., 2005, 5, 249-257.
63. 1-antitrypsin deficiency. Lancet, 2005, 365, 2225-2236.
64. 1-antitrypsin deficiency. Thorax, 2004, 59, 164-169.
65. Lomas, D. A.; Belorgey, D.; Mallya, M.; Miranda, E.; Kinghorn, K. J.; Sharp, L. K.; Phillips, R. L.; Page, R.; Robertson, A. S.; Crowther, D.C. Molecular mousetraps and the serpinopathies. Biochem. Soc. Trans., 2005, 33, 321-330.
66. 1-antitrypsin and to Carl-Bertil Laurell, COPD, 2004, 1, 71-84.
67. 1-antitrypsin deficiency. Chest, 2002, 122, 1818-1829.
68. 1-antitrypsin deficiency in European countries. Eur. Respir. J., 2005, 27, 1-8.
69. 1-antitrypsin PI S and PI Z frequencies in countries outside Europe : a meta-analysis. Clin. Genet., 2001, 60, 431-441.
70. Schindler, D. In Human Genetic Disorders : 16th' Miami Winter Symposium. Advances in Gene Technology ; Ahmad, S.; Black, J.; Schulz, W.; Scott Whelan, J.; Eds.; Cambridge University Press : Cambridge, UK, 1984, p. 32.
71. Curiel, D. T.; Chytil, A.; Courtney, M.; Crystal, R. G. Serum α 1-antitrypsin deficiency associated with the common S-type ( Glu→ 264 Val) mutation results from intracellular degradation of α 1-antitrypsin prior to secretion. J. Biol. Chem., 1989, 264, 10477-10486.
72. 1-antitrypsin. Am. J. Hum. Genet., 1977, 29, 233-239.
73. Long, G. L.; Chandra, T.; Woo, S. L. C.; Davie, E. W.; Kurachi, K. Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant. Biochemistry, 1984, 23, 4828-4837.
74. 1-antitrypsin, structure and implications for function and metabolism. Protein. Eng., 1989, 2, 407-415.
75. 1-antitrypsin of Pi types S, and MMalton and of asialylated M-protein in man. Clin. Sci. Mol. Med., 1978, 55, 103-107.
76. 1-antitrypsin as an in vivo and in vitro inhibitor of neutrophil elastase. Am. Rev. Respir. Dis., 1988, 137, 364-370.
77. 1-antitrypsin and liver cirrhosis. J. Clin. Invest.,1999, 103, 999-1006.
78. 1-antitrypsin. J. Biol. Chem., 1999, 274, 9548-9555.
79. 1-antitrypsin PiZ. FEBS. Lett., 1976, 65, 195-197.
80. 1-antitrypsin accumulation in the liver. Nature, 1992, 357, 605-607.
81. Skinner, R.; Chang, W. S. W.; Jin, L.; Pei, X.; Huntington, J. A.; Abrahams, J. P.; Carrell, R. W.; Lomas, D. A. Implications for function and therapy of a 2.9 A° structure of binary-complexed antithrombin. J. Mol. Biol., 1998, 283, 9-14.
82. 1-antitrypsin deficiency-related emphysema. Am. J. Respir. Cell. Mol. Biol., 1998, 18, 670-674.
83. 1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo. Am. J. Pathol., 2005, 166, 377-386.
84. 1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant. Chest, 2004, 125, 1952-1957.
85. 1-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysema. Am. J. Respir. Cell. Mol. Biol., 2002, 26, 723-730.
86. 1-antitrypsin deficiency: an experience in 29 children and ten adults. Transplant. Proc., 1987, 19, 3798-3802.
87. 1-antitrypsin deficiency in children : pretransplant natural history, timing and results of transplantation. J. Hepatol., 1994, 20, 72-78.
88. 1-antitrypsin phenotype after orthotopic liver transplant. Clin. Exp. Immunol., 1986, 66, 669-672.
89. 1- antitrypsin. Transplantation, 1996, 61, 1488-1495.
90. Casolaro, M. A.; Fells, G.; Wewers, M.; Pierce, J. E.; Ogushi, F.; Hubbard, R.; Sellers, S.; Forstrom, J.; Lyons, D.; Kawasaki, G.; Crystal, R.G. Augmentation of lung antineutrophil elastase capacity with recombinant human alpha-1-antitrypsin. J. Appl. Physiol., 1987, 63, 2015-2023.
91. 1-antitrypsin augmentation therapy. Am. Rev. Respir. Dis., 1987, 135, 539-543.
92. 1-antitrypsin deficiency associated with emphysema. N. Engl. J. Med., 1987, 316, 1055-1062.
93. 1-antitrypsin. Patterns of use and adverse events. Chest, 2003, 123, 425-34.
94. 1-antitrypsin. Eur. Respir. J., 1998, 11, 428-433.
95. Hubbard, R. C.; Seller, S.; Czerski, D.; Stephens, L.; Crystal, R. G. Biochemical efficacy and safety of monthly augmentation therapy for alpha 1-antitrypsin deficiency. JAMA, 1988, 260, 1259-1264.
96. 1-antitrypsin gene to lungs of rabbits. Am. J. Respir. Cell. Mol. Biol., 1994, 10, 24-29.
97. 1- antitrypsin in mice after direct gene delivery in vivo. Hum. Gene. Ther., 1992, 3, 641-647.
98. Rosenfeld, M. A.; Siegfried, W.; Yoshimura, K.; Yoneyama, K.; Fukayama, M.; Stier, L. E.; Pääkkö, P. K.; Gilardi, P.; Stratford-Perricaudet, L. D.; Perricaudet, M.; Jallat, S.; Pavirani, A.; Lecocq J. P.; Crystal, R.G. Adenovirus-mediated transfer of a recombinant alpha-1-antitrypsin gene to the lung epithelium in vivo. Science, 1999, 252, 431-434.
99. Song, S.; Morgan, M.; Ellis, T.; Poirier, A.; Chesnut, K.; Wang, J.; Brantly, M.; Muzyczka, N.; Byrne, B. J.; Atkinson, M.; Flotte, T. R. Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc. Natl. Acad. Sci. U S A., 1998, 95, 14384-14388.
100. 1-antitrypsin by a peptide sequentially similar to β-strand s4A. Eur. J. Biochem., 1990, 194, 51-56.
101. 1-antitrypsin. Biochemistry, 1993, 32, 500-508.
102. Fitton, H. L.; Pike, R. N.; Carrell, R. W.; Chang, W. S. W. Mechanisms of antithrombin polymerisation and heparin activation probed by the insertion of synthetic reactive loop peptides. Biol. Chem., 1997, 378, 1059-1063.
103. Chang, W. S.; Wardell, W. M. R.; Lomas, D. A.; Carell, R.W. Probing serpin reactive-loop conformations by proteolytic cleavage. Biochem. J., 1996, 314, 647-653.
104. 1- antitrypsin-related cirrhosis. J. Biol. Chem., 2002, 277, 6771-6774.
105. 1-antitrypsin-related emphysema. Am. J. Respir. Cell. Mol. Biol., 2004, 31, 133-139.
106. 1-antitrypsin. Am. J. Resp. Cell. Mol. Biol., 2006, 35, 540-548.
107. 1-AT deficiency. Am. J. Respir. Cell. Mol. Biol., 2001, 24, 727-732.
108. 1-AT deficiency. Proc. Natl. Acad. Sci. USA, 2000, 97, 1796-1801.
109. 1-antitrypsin deficiency in Japan. Am. J. Respir. Crit. Care. Med., 1995, 152, 2119-2126.
110. 1- antitrypsin-deficient variant with mutation on a predicted conserved residue of the serpin backbone. J. Biol. Chem., 1991, 266, 12627-12632.
111. Nukiwa, T.; Satoh, K.; Brantly, M. L.; Ogushi, F.; Fells, G. A.; Courtney, M.; Crystal, R. Identification of a second mutation in the protein-coding sequence of the Z type alpha 1-antitrypsin gene. J. Biol. Chem., 1986, 261, 15989-15994.
112. 1-antitrypsin Siiyama (Ser53 Phe): further evidence for intracellular loop-sheet polymerization. J. Biol. Chem., 1993, 268, 15333-15335.
113. 1-antitrypsin: electrophoretic variation and DNA haplotypes. Am. J. Hum. Genet., 1989, 44, 844-854.
114. Cox, D. W. In Protides of the Biological Fluids ; Peters, H.; Ed.; Pergammon: Oxford, 1975; Vol. 23, pp. 375-378.
115. 1 -antitrypsin gene. Cell, 1985, 41, 531-540.
116. 1- antitrypsin. Am. J. Hum. Genet., 1989, 44, 894-902.
117. 1-antitrypsin suggests basic defect for the deficiency. FEBS. Lett., 1986, 205, 255-260.
118. 1-antitrypsin deficiency in 155 patients with alcoholic liver disease. Am. J. Clin. Pathol., 1984, 82, 424-427.
119. 1-antitrypsin Mmalton (Phe52-deleted) forms loop-sheet polymers in vivo: evidence for the C sheet mechanism of polymerization. J. Biol. Chem., 1995, 270, 16864-16870.
120. 1 - antitrypsin deficiency allele Mmalton. J. Biol. Chem., 1989, 264, 13938-13945.
121. Mittman, C.; Barbela, T.; Lieberman, J. Antitrypsin deficiency and abnormal protease inhibitor phenotypes. Arch. Environ. Health., 1973, 27, 201-206.
122. Pierce, J. A.; Eradioo, B.; Dew, T. A. Antitrypsin phenotypes in St. Louis. JAMA, 1975, 231, 609-612.
123. 1-antitrypsin. Hum. Genet., 1982, 61, 118-122.
124. Fagerhol, M. K.; Braend, M. Serum prealbumin: polymorphism in man. Science, 1965, 149, 986-987.
125. Mittman, C.; Lieberman, J. Protease inhibitor phenotypes in patients with chronic lung disease Clin. Res., 1972, 20, 242-243.
126. 1-antitrypsin phenotype. Can. Med. Assoc. J., 1981, 124, 737-742.
127. 1-antitrypsin associated with pulmonary disease?. Clin. Genet., 1984, 25, 491-495.
128. Kelly, C.; Tyrrell, D.; McDonald, G.; Whitehouse, D.; Prichard, J. Heterozygous FZ alpha 1 antitrypsin deficiency associated with severe emphysema and hepatic disease: case report and family study. Thorax, 1989, 44, 758-759.
129. 1-antitrypsin F allele. J. Hum. Genet., 1991, 48, 1154-1158.
130. Thornton, J. M. Disulphide bridges in globular proteins. J. Mol. Biol., 1981, 151, 261-287.
131. 1- antitrypsin. Int. J. Clin. Lab. Res., 1992, 22, 119-121.
132. 1-antitrypsin "deficiency" allele Mprocida. J. Biol. Chem., 1988, 263, 15528-15534.
133. Kim, P. S.; Baldwin, R. L. A helix stop signal in the isolated S-peptide of ribonuclease A. Nature, 1984, 307, 329 - 334.
134. 1-antitrypsin deficiency variant PI MHeerlen. Hum. Genet., 1989, 81, 264-268.
135. 1-antitrypsin Mmineral sprngs allele. Mol. Cell. Biol., 1990, 10, 47-56.
136. 1- antitrypsin deficiency variant, Mnichinan. Am. J. Hum. Genet., 1990, 46, 602-612.
137. Suzuki, K.; Deyashiki, Y.; Nishioka, J.; Kurachi, K.; Akira, M.; Yamamoto, S.; Hashimoto, S. Characterization of a cDNA for human protein C inhibitor: a new member of the plasma serine protease inhibitor superfamily J. Biol. Chem., 1987, 262, 611-616.
138. 1 - antitrypsin for structure and function of serpins. Biochemistry, 1989, 28, 8951-8966.
139. 1-antitrypsin phenotypes. Chest, 1991, 100, 703-708.
140. 1-antitrypsin deficiency variant Pduarte. Hum. Mutat., 1993, 2, 221-228.
141. Brantly, M.; Hildesheim, J.; Laubach, V.; Rundquist, B.; Paul, L. α1-antitrypsin Null new hope: natural conversion of the α1-antitrypsin deficiency Z variant into a null variant by the addition of a second amino acid substitution. Clin. Res., 1992, 40, 328A.
142. Faber, J. Molekulargenetische aufklarung von mutanten des alpha 1- antitrypsin-und des alpha 1-antichymotrypsin-gens PhD Thesis , Rheinischen Friedrich Wilhelms Universitat , Bonn 1991.
143. Weidinger, S.; Jahn, W.; Cujnik, F.; Schwarzfischer, F. alpha-1-antitrypsin: evidence for a fifth PI M subtype and a new deficiency allele PI *ZAugsburg. Hum. Genet., 1985, 71, 27-29.
144. Owen, M. C.; Brennan, S. O.; Lewis, J. H.; Carrell, R. W. Mutation of antitrypsin to antithrombin. Alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder. N. Engl. J. Med., 1983, 309, 694-698.
145. 5 position does not affect inhibitory activity. Biochim. Biophys. Acta., 1986, 873, 13-19.
146. 1-antitrypsin phenotype samples. Clin. Chem., 1984, 30, 1588.
147. Fagerhol, M. K.; Cox, D. W. In Advances in Human Genetics; Harris, H.; Hirschorn, K.; Eds.; Plenum Press : New York, 1981, pp.1-62.
148. munich : a variant associated with a unique protein isoelectric focusing pattern. Am. J. Hum. Genet., 1990, 46, 810-816.
149. 1-antitrypsin deficiency variant. Biochem. Biophys. Res. Commun., 1990, 170, 1013-1020.
150. 1-antitrypsin deficient allele PI YBarcelona (Asp256Val and Pro391His). Hum. Mutat., 1998, 12, 213.
151. Olds, R. J.; Lane, D. A.; Caso, R.; Panico, M.; Morris, H. R.; Sas, G.; Dawes, J.; Thein, S. L. Antithrombin III Budapest : a single amino acid substitution (429Pro to Leu) in a region highly conserved in the serpin family. Blood, 1992, 79, 1206-1212.
152. 1-antitrypsin deficiency. Chest, 1996, 110, 237-242.
153. Verpy, E.; Coture-Tosi, E.; Eldering, E.; Lopez -Trascasa, M.; Spath, P.; Meo, T.; Tosi, M. Crucial residues in the carboxyterminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function. J. Clin. Invest., 1995, 95, 350-359.
154. Stein, P. E. ; Carrell, R. W. What do dysfunctional serpins tell us about molecular mobility and disease?.Nat. Struct. Biol., 1989, 2, 96-113.
155. 1- proteinase inhibitor requires an almost full length molecule. J. Biol. Chem., 1992, 267, 294-297.
156. 1-antitrypsin indicate a single origin for deficiency allele PI Z. Nature, 1985, 316, 79-81.
157. 1-antitrypsin variant PI Zaugsburg. Am. J. Hum. Genet., 1990, 46, 1158-1162.
158. bristol) associated with novel electrophoretic properties. Ann. Hum. Genet., 1997, 61, 385-391.
159. Helenius, A. How N-linked oligosaccharides affect glycoprotein folding in the endoplasmic reticulum. Mol. Biol. Cell., 1994, 5, 253-265.
160. Mitra, N.; Sharon, N.; Surolia, A. Role of N-linked glycan in the unfolding pathway of Erythrina corallodendron lectin. Biochemistry, 2003, 42, 12208-12216.
161. O'Connor, S. E.; Imperiali, B. Modulation of protein structure and function by asparagine-linked glycosylation. Chem. Biol., 1996, 3, 803-812.
162. 1-antitrypsin (null homozygotes). Am. Rev. Respir. Dis., 1988, 137, 371-375.
163. Carrell, R. W.; Pemberton, P.; Boswell, D. R. The serpins: evolution and adaptation in a family of protease inhibitors. Cold. Spring. Harb. Symp. Quant. Biol., 1987, 52, 527-535.
164. 1- antitrypsin in conjunction with an apparently normal gene structure. Am. J. Human. Genet., 1986, 38, 898-907.
165. Higgins, C. F. Stability and degradation of mRNA. Curr. Opin. Cell. Biol., 1991, 3, 1013-1018.
166. Sachs, A. B. Messenger RNA degradation in eukaryotes. Cell, 1993, 74, 413-421.
167. Belgrader, P.; Maquat, L. E. Nonsense but not missense mutations can decrease the abundance of nuclear mRNA for the mouse major urinary protein, while both types of mutations can facilitate exon skipping. Mol. Cell. Biol., 1994, 14, 6326-6336.
168. 1- antitrypsin null alleles. Respir. Med., 2000, 94, S7-S11.
169. Cheng, J.; Fogel-Petrovic, M.; Maquat, L. E. Translation to near the distal end of the penultimate exon is required for normal levels of spliced triosephosphate isomerase mRNA. Mol. Cell. Biol., 1990, 10, 5215-5225.
170. 1-antitrypsin genes. N. Engl. J. Med., 1986, 314, 762-766.
171. 1-antitrypsin gene. Am. J. Hum. Genet., 1987, 41, 891-906.
172. Wintersberger, U. On the origins of genetic variants. FEBS. Lett., 1991, 285, 160-164.
173. Thompson, J. D.; Higgins, D. G.; Gibson, T. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res., 1994, 22, 4673-4680.
174. Felenstein, J. PHYLIP-phylogeny inference package (version 3.2). Cladistic, 1989, 5, 164-166.
175. Gilbert, D.G. Phylodendron, Java software for phylogenetic tree drawing. Bionet. Software, January 1997.
176. 1-antitrypsin deficiency 4: molecular pathophysiology. Thorax, 2004, 59, 529-535.